The University of Queensland and CSIRO are building a new world-class $4.5 million initiative to boost Australia’s synthetic biology capabilities.
Colin Scott is a Principal Research Scientist working at CSIRO, Canberra. He also runs the CSIRO Biocatalysis and Synthetic Biology Team and he’s a Synthetic Biology Future Science Platform Domain Leader (Chemicals & Fibres).
We are excited to present synthetic biologist, Dr Karen Weynberg, who is the ECR representative of SBA Executive Board. Karen is a CSIRO Future Science Research Fellow based at University of Queensland.
She completed her PhD in the UK in 2009, uncovering new viruses that infect marine phytoplankton. Her first fellowship, the ARC Super Science Research Fellowship, investigated the role of viruses in coral reefs. Her current fellowship uses synthetic biology to develop phage therapy for addressing bacterial biofilms and antibiotic resistance. Suffice to say that Karen is something of a virus aficionado, and has even given a TedX talk and media interviews to BBC News and ABC News. Twitter handle: @ReefViruses